Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000904454-07-000319
Filing Date
2007-05-18
Accepted
2007-05-18 14:32:40
Documents
2
Period of Report
2007-05-16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3756
2 O:\DATA\FORMS 3,4&5\HALAK\HALAK_050107-POA.HTM halak_050107-poa.htm EX-24 3329
  Complete submission text file 0000904454-07-000319.txt   8946
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 300 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 300 ROCKVILLE MD 20850 240-599-4500
Vanda Pharmaceuticals Inc. (Issuer) CIK: 0001347178 (see all company filings)

EIN.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DOMAIN ASSOCIATES ONE PALMER SQUARE PRINCETON NJ 08542
Business Address (609)683-5656
Halak Brian K (Reporting) CIK: 0001354718 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51863 | Film No.: 07864310